Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Seynaeve

Showing results (41-50 of 175) with videos related to

Pageof 18
Sort By:
European Journal of Cancer (Oxford, England : 1990)|May 26, 2005
Exploring the course of psychological distress around two successive control visits in women at hereditary risk of breast cancerSilvia van Dooren, Caroline Seynaeve, Adriana J Rijnsburger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutationHanne Meijers-Heijboer, Cecile T M Brekelmans, Marian Menke-Pluymers, et al.
American Journal of Medical Genetics. Part A|June 5, 2003
Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testingLitanja Lodder, Petra G Frets, R Willem Trijsburg, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|November 28, 2008
High satisfaction rates in women after DIEP flap breast reconstructionTim H C Damen, Reinier Timman, Ellen H Kunst, et al.
Cancer|July 16, 2011
The efficacy of taxane chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriersMieke Kriege, Agnes Jager, Maartje J Hooning, et al.
Molecular Oncology|December 27, 2015
The influence of insulin-like Growth Factor-1-Receptor expression and endocrine treatment on clinical outcome of postmenopausal hormone receptor positive breast cancer patients: A Dutch TEAM substudy analysisCharla C Engels, Nienke A de Glas, Anita Sajet, et al.
Cancer Biology & Therapy|January 16, 2014
Lower mitotic activity in BRCA1/2-associated primary breast cancers occurring after risk-reducing salpingo-oophorectomyVictorien Mt van Verschuer, Bernadette Am Heemskerk-Gerritsen, Carolien Hm van Deurzen, et al.
The Oncologist|January 5, 2019
Impact of Comorbidities and Age on Cause-Specific Mortality in Postmenopausal Patients with Breast CancerMarloes G M Derks, Cornelis J H van de Velde, Daniele Giardiello, et al.
Plastic and Reconstructive Surgery|May 3, 2006
Satisfaction with prophylactic mastectomy and breast reconstruction in genetically predisposed womenPaula J C Bresser, Caroline Seynaeve, Arthur R Van Gool, et al.
Journal of the National Cancer Institute|March 21, 2014
External validity of a trial comprised of elderly patients with hormone receptor-positive breast cancerWillemien van de Water, Mandy Kiderlen, Esther Bastiaannet, et al.
Pageof 18

Showing results (41-50 of 175) with videos related to

Sort By:
Pageof 18
European Journal of Cancer (Oxford, England : 1990)|May 26, 2005
Exploring the course of psychological distress around two successive control visits in women at hereditary risk of breast cancerSilvia van Dooren, Caroline Seynaeve, Adriana J Rijnsburger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutationHanne Meijers-Heijboer, Cecile T M Brekelmans, Marian Menke-Pluymers, et al.
American Journal of Medical Genetics. Part A|June 5, 2003
Attitudes and distress levels in women at risk to carry a BRCA1/BRCA2 gene mutation who decline genetic testingLitanja Lodder, Petra G Frets, R Willem Trijsburg, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|November 28, 2008
High satisfaction rates in women after DIEP flap breast reconstructionTim H C Damen, Reinier Timman, Ellen H Kunst, et al.
Cancer|July 16, 2011
The efficacy of taxane chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriersMieke Kriege, Agnes Jager, Maartje J Hooning, et al.
Molecular Oncology|December 27, 2015
The influence of insulin-like Growth Factor-1-Receptor expression and endocrine treatment on clinical outcome of postmenopausal hormone receptor positive breast cancer patients: A Dutch TEAM substudy analysisCharla C Engels, Nienke A de Glas, Anita Sajet, et al.
Cancer Biology & Therapy|January 16, 2014
Lower mitotic activity in BRCA1/2-associated primary breast cancers occurring after risk-reducing salpingo-oophorectomyVictorien Mt van Verschuer, Bernadette Am Heemskerk-Gerritsen, Carolien Hm van Deurzen, et al.
The Oncologist|January 5, 2019
Impact of Comorbidities and Age on Cause-Specific Mortality in Postmenopausal Patients with Breast CancerMarloes G M Derks, Cornelis J H van de Velde, Daniele Giardiello, et al.
Plastic and Reconstructive Surgery|May 3, 2006
Satisfaction with prophylactic mastectomy and breast reconstruction in genetically predisposed womenPaula J C Bresser, Caroline Seynaeve, Arthur R Van Gool, et al.
Journal of the National Cancer Institute|March 21, 2014
External validity of a trial comprised of elderly patients with hormone receptor-positive breast cancerWillemien van de Water, Mandy Kiderlen, Esther Bastiaannet, et al.
Pageof 18